Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports.

European Journal of Clinical Pharmacology
Marie-Louise JohanssonSusanna M Wallerstedt

Abstract

Spontaneous reporting of adverse drug reactions (ADRs) is one approach to increasing our knowledge on the risks of drugs in clinical practice. Under-reporting is a shortcoming of this system. To evaluate if repeated e-mails with attachments on ADR information can affect (1) the reporting of ADRs and (2) the quality of the ADR reports. All 117 heads of primary health care units in the region of Västra Götaland in Sweden were randomly allocated (1:1) to an intervention group or a control group. The intervention consisted of e-mails with attachments sent out to each of the 117 heads in January, May and September 2007. These e-mails included (1) the heading "Every ADR report is important", (2) a current case report of an ADR and (3) instructions on how to report. The number of reports from each primary health care unit run by the same head was registered, as was the quality of the report. The quality was defined as high if the ADR was (1) serious, (2) unexpected or (3) related to the use of new drugs and not labeled as common in the summary of product characteristics. All other reports were regarded as low-quality reports. The total number of reports increased from 89 in 2006 to 111 in 2007 (P = 0.037). No difference in the number ...Continue Reading

References

Jul 1, 1997·British Journal of Clinical Pharmacology·P McGettiganJ Feely
Oct 17, 1998·European Journal of Clinical Pharmacology·A Alvarez-RequejoL H Arias
May 21, 1999·European Journal of Clinical Pharmacology·P M van den BemtH G Leufkens
Feb 24, 2001·European Journal of Clinical Pharmacology·M BäckströmT Nordkvist-Olsson
May 10, 2002·Pharmacoepidemiology and Drug Safety·Tom MjörndalRune Dahlqvist
Oct 30, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Josep Maria CastelDolors Capellà
Jul 23, 2004·Pharmacoepidemiology and Drug Safety·M BäckströmR Dahlqvist
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroJuan Jesus Gestal-Otero
Sep 7, 2006·JAMA : the Journal of the American Medical Association·Adolfo FigueirasJuan Jesus Gestal-Otero
Mar 10, 2007·European Journal of Clinical Pharmacology·Susanna M WallerstedtLars Ny
Apr 4, 2007·European Journal of Clinical Pharmacology·M BäckströmT Mjörndal

❮ Previous
Next ❯

Citations

Jun 19, 2012·European Journal of Clinical Pharmacology·Chiara BiagiDomenico Motola
Dec 3, 2013·International Journal of Technology Assessment in Health Care·Caroline PagottoPatrícia Mastroianni
May 4, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Cristian Gonzalez-GonzalezAdolfo Figueiras
Jan 31, 2016·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Allison Salk, Eli D Ehrenpreis
Mar 2, 2016·BMC Medical Informatics and Decision Making·Inês Ribeiro-VazRicardo Cruz-Correia
Jul 16, 2013·Journal of Clinical Pharmacology·Lee Hilary GoldsteinMatitiyahu Berkovitch
May 5, 2016·Revista de saúde pública·Inês Ribeiro-VazRicardo Cruz-Correia
Feb 24, 2015·The Cochrane Database of Systematic Reviews·Clare GoyderJosip Car
May 21, 2020·Pharmacoepidemiology and Drug Safety·Malahat KhaliliAli Akbar Haghdoost
Jul 6, 2021·Journal of General and Family Medicine·Kenya IeSteven M Albert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.